139TiPPHASE 2, OPEN-LABEL, INTERNATIONAL, NON-COMPARATIVE STUDY OF MEDI4736 IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC, PD-L1 + , STAGE 3B–4 NSCLC WHO HAVE RECEIVED ≥2 PRIOR SYSTEMIC TREATMENT REGIMENS (ATLANTIC)


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles